These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4537012)

  • 21. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Kasper CK; Aronson DL; Davignon G; Foster P; Hillman-Wiseman C; Lusher JM; Manco-Johnson M; Meade JB; Montgomery RR; Rickles FR
    Thromb Haemost; 1995 Sep; 74(3):987-9. PubMed ID: 8571334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihemophilic factor release by perfused liver and spleen: relationship to hemophilia.
    Norman JC; Lambilliotte JP; Kojima Y; Sise HS
    Science; 1967 Nov; 158(3804):1060-1. PubMed ID: 6058346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The physiologic basis for therapy of classic hemophilia (factor 8 deficiency) and related disorders. Combined clinical staff conference at the National Institutes of Health.
    Ann Intern Med; 1967 Oct; 67(4):856-82. PubMed ID: 5299081
    [No Abstract]   [Full Text] [Related]  

  • 24. Antihaemophilic-factor-like protein in haemophilia.
    Ekert H; Helliger H; Muntz RH
    Med J Aust; 1973 Aug; 2(5):210-2. PubMed ID: 4542740
    [No Abstract]   [Full Text] [Related]  

  • 25. Canine von Willebrand's disease.
    Dodds WJ
    J Lab Clin Med; 1970 Nov; 76(5):713-21. PubMed ID: 5312238
    [No Abstract]   [Full Text] [Related]  

  • 26. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
    Uszyński L
    Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276
    [No Abstract]   [Full Text] [Related]  

  • 27. The genetics of clotting factor VIII.
    Ingram GI
    Med Lab Technol; 1971 Jan; 28(1):76-80. PubMed ID: 5313886
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the characterization of factor VIII and a co-factor VIII.
    Paulssen MM; Vandenbussche-Scheffers HL; Spaan PB; de Jong T; Planje MC
    Thromb Diath Haemorrh; 1974 May; 31(2):328-38. PubMed ID: 4546924
    [No Abstract]   [Full Text] [Related]  

  • 29. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
    Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Partial characterization of the factor VIII-stimulating material of rabbit liver perfusates: relationships to rabbit plasma factor VIII.
    Benson RE; Dodds WJ
    Br J Haematol; 1975 Dec; 31(4):437-47. PubMed ID: 829749
    [No Abstract]   [Full Text] [Related]  

  • 31. Spleen and coagulation factors.
    Hiçsönmez G; Ozsoylu S
    Turk J Pediatr; 1982; 24(3):143-50. PubMed ID: 6815846
    [No Abstract]   [Full Text] [Related]  

  • 32. A factor VIII minigene comprising the truncated intron I of factor IX highly improves the in vitro production of factor VIII.
    Plantier JL; Rodriguez MH; Enjolras N; Attali O; Négrier C
    Thromb Haemost; 2001 Aug; 86(2):596-603. PubMed ID: 11522009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the reaction product of factor 8 and factor IX by gel filtration.
    Hougie C; Denson KW; Biggs R
    Thromb Diath Haemorrh; 1967 Aug; 18(1-2):211-22. PubMed ID: 6071104
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical aspects of hemophilia and von Willebrand's disease.
    Ciavarella D; Counts RB
    Am J Med Technol; 1983 Dec; 49(12):850-4. PubMed ID: 6422754
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatic influence on splenic synthesis and release of coagulation activities.
    Dodds WJ
    Science; 1969 Nov; 166(3907):882-3. PubMed ID: 5307348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982).
    Christensen RL; Triplett DA
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):633-42. PubMed ID: 6414289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1981 Jun; 45(3):242-6. PubMed ID: 6792738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.
    Meyer D; Obert B; Pietu G; Lavergne JM; Zimmerman TS
    J Lab Clin Med; 1980 Apr; 95(4):590-602. PubMed ID: 6965697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.